News and Comments

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...


Recent Postings


Archive


Tags

Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) Illumina (ILMN) ABBVIE (ABBV) SERES THERAPEUTICS (MCRB) Incyte (INCY) Ziofpharm (ZIOP) BIOMARIN (BMRN) AERIE PHARMACEUTICALS Anadys (ANDS) Telaprevir Auspex (ASPX) Gilead (GILD) Sanofi (SNA) C4 Therapeutics ZALTRAP™ GUARDIAN HEALTH Zerenex Micromet (MITI) Prolor Biotech (PBTH) Galena (GALE) Sangamo (SGMO) Roche (ROCHE) Prosensa (RNA) Roche (RHHBY) Tysabri Seattle Genetics (SGEN) KITE (KITE) Merck (MRK) Mirati Therapeutics (MRTX) NANTKWEST (NK) galapagos (GLPG) Dendreon (DNDN) SYNTA (SNTA) HALOZYME (HALO) Exelixis (EXEL) Sanofi (SNY) NEKTAR (NKTR)) Multiple Myeloma TOKAI (TKAOI) Herceptin Agenus (AGEN Agenus (AGEN) Revlimid (lenolidamide) VANDA (VNDA) Theravance (THRX) Vertex (VRTX) Human Genome Sciences (HGSI) KERYX (KERX) IDERA (IDRA) ARCA (ABIO) Velcade (bortezomib) Ridaforolimus Benlysta (belimumab) Amgen (AMGN) Inovio (INO) Genentech Aimmune Therapeutics (AIMT) SUNESIS PHARMACEUTICALS (SNSS) ADVENTRIX (ANX) Intrexon (XON) Cytokinetics (CYTK) Intermune (ITMN) Sequenom (SQNM) Endometrial Cancer Rapamune Pluristem (PSTI) Array Pharmaceuticals (ARRY) Anacor (ANAC) ImmunoGen (IMGN) Alnylam (ALNY) Regeneron (REGN) OSI (OSIP) Bristol-Myers Squibb (BMY) Biocryst (BCRX) Xoma (XOMA) Idenix (IDIX) GlaxoSmithKline (GSK) Abbott Laboratories (ABT) Dynavax (DVAX) Trastuzumab-DM1 Ariad (ARIA) Elan (ELN) Onyx (ONXX) Sanofi-Aventis (SAN) JUNO (JUNO) CompuGen (CGEN) ISIS (ISIS) Biogen Idec (BIIB) Intercept (ICPT) Valeant Pharmaceuticals International (VRX)